Atara Biotherapeutics (ATRA) Tax Rate (2013 - 2026)
Atara Biotherapeutics' (ATRA) quarterly Tax Rate came in at 0.02% in Q2 2026, down 15.0% on a YoY basis from 0.02% in Q2 2025, and up 99.99% quarter-over-quarter from 201.89% in Q4 2025.
Powered by 
Analysis
Atara Biotherapeutics (ATRA) Tax Rate (2013 - 2026) Analysis & Trends
Atara Biotherapeutics (ATRA) has reported Tax Rate for 14 consecutive years, with 0.02% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Tax Rate fell 15.0% year-over-year to 0.02%; the trailing twelve-month figure through Jun 2026 stood at 41.28% (down 4070.0% YoY), and the FY2025 full-year result was 20.99%, up 2097.0% from the prior year.
- Tax Rate rose to 0.02% in Q2 2026 per ATRA's latest filing, from 201.89% in the prior quarter.
- Across five years, Tax Rate topped out at 0.15% in Q4 2024 and bottomed at 201.89% in Q4 2025.
- Historically, Tax Rate has averaged 15.56% across 5 years, with a median of 0.01% in 2022.
- The sharpest annual moves came in 2024 and 2025: Tax Rate rose 17 bps in 2024, then tumbled 20204 bps in 2025.
- Over 5 years, Tax Rate stood at 0.0% in 2022, then tumbled by 577 bps to 0.02% in 2023, then surged by 925 bps to 0.15% in 2024, then tumbled by 135174 bps to 201.89% in 2025, then surged by 100 bps to 0.02% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 0.02%, 201.89%, and 0.65% for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.28 Bn | 9.43 Bn | 112.79 Mn | 17.12% |
| 2 | CRISPR Therapeutics AG | 5.04 Bn | 5.04 Bn | - | -1.11% |
| 3 | Iovance Biotherapeutics | 3.66 Bn | 3.36 Bn | 55.72 Mn | 2.88% |
| 4 | Legend Biotech | 3.54 Bn | 2.57 Bn | 251.50 Mn | -40.18% |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn | -2.32% |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - | - |
| 7 | Precigen | 2.38 Bn | 2.38 Bn | 52.17 Mn | - |
| 8 | Sarepta Therapeutics | 2.16 Bn | 1.37 Bn | 251.87 Mn | -179.59% |
| 9 | Vericel | 1.94 Bn | 1.78 Bn | 56.40 Mn | - |
| 10 | Atara Biotherapeutics | 143.11 Mn | 126.56 Mn | 439,000.00 | -0.02% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.02% |
| Dec 31, 2025 | -201.89% |
| Sep 30, 2025 | -0.65% |
| Jun 30, 2025 | 0.13% |
| Dec 31, 2024 | 0.15% |
| Sep 30, 2024 | 0.08% |
| Mar 31, 2024 | -0.08% |
| Dec 31, 2023 | -0.02% |
| Sep 30, 2023 | 0.03% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | -0.03% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | -0.01% |
| Dec 31, 2021 | -0.03% |
| Jun 30, 2021 | -0.02% |
| Dec 31, 2020 | -0.01% |
| Sep 30, 2020 | -0.01% |
| Jun 30, 2020 | 0.00% |
| Dec 31, 2019 | -0.02% |
| Dec 31, 2018 | 0.06% |